SunGen Pharma Receives Eighth ANDA Approval from FDA

Published Online: Thursday, October 31st, 2019
SunGen Pharma, the specialty pharmaceutical company, has received its eighth ANDA approval from the FDA.
 
The approval is for Lidocaine Ointment USP, 5%, used for the production of anesthesia of accessible mucous membranes of the oropharynx.
 
The product is also used as an anesthetic lubricant for intubation and for the temporary relief of pain associated with minor burns. Lidocaine has annual sales of about 60 million US dollars.
 
Reference
 
SunGen Pharma receives eighth ANDA approval from US FDA [news release]. Princeton, NJ; Globe Newswire: October 31, 2019. https://www.globenewswire.com/news-release/2019/10/31/1939048/0/en/SunGen-Pharma-Receives-Eighth-ANDA-Approval-from-US-FDA.html. Accessed October 31, 2019.



Current Issue

The Educated Patient

Katarzyna Lalicata, MSN, FNP-C, FNP-BC
The symptoms associated with colds, most commonly congestion, coughing, sneezing, and sore throats, are the body's response when a virus exerts its effects on the immune system. Cold symptoms peak at about 1 to 2 days and last 7 to 10 days but can last up to 3 weeks.
Kristen L. Marjama, DNP, APRN-BC, FNP
Exposure to damp and moly environments may also result in a variety of other health issues.
Bethany Rettberg, NPC
An accurate medical history and a physical exam are critical to rule out more serious conditions.
Bethany Rettberg, NPC
Practitioners should get a detailed medical history and conduct a thorough physical to treat sinus infections.
$vacMongoViewPlus$ $vAR$
Contemporary Clinic
MJH Associates
American Journal of Managed Care
Cure
MD Magazine
ONCLive
OTCGuide
Pharmacy Times
Specialty Pharmacy Times
Targeted Oncology
About Us
Advertise
Careers
Contact Us
Feedback
Privacy
Terms & Conditions
Pharmacy Healthcare & Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-257-0701

Copyright Contemporary Clinic 2019
Pharmacy Healthcare & Communications, LLC. All Rights Reserved.